A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Nativi, Cristina ^a   Gualdani, Roberta ^a   Dragoni, Elisa ^a   Di Cesare Mannelli, Lorenzo ^b   Sostegni, Silvia ^a   Norcini, Martina ^a   Gabrielli, Gabriele ^a   La Marca, Giancarlo ^b   Richichi, Barbara ^a   Francesconi, Oscar ^a   Moncelli, Maria Rosa ^a   Ghelardini, Carla ^b   Roelens, Stefano ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Dipartimento NeuroFarBa   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTINEOPLASTIC AGENT; OXALIPLATIN; PLATINUM COMPLEX; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRPA1 PROTEIN, RAT;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; NEURALGIA; RAT; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED;

ANALGESICS; ANIMALS; ANTINEOPLASTIC AGENTS; NEURALGIA; ORGANOPLATINUM COMPOUNDS; RATS; TRPC CATION CHANNELS;

EID: 84879622275     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02005     Document Type: Article

References (34)

1. Sherrington, C. S. Observation on the scratch-reflex in the spinal dog. J. Physiol. 34, 1-50 (1905).
2. Woolf, C. J. & Mannion, R. J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353, 1959-1964 (1999).
3. Gilron, I., Watson, C. P., Cahill, C. M. & Moulin, D. E. Neuropathic pain: a practical guide for the clinician. Can. Med. Ass. J. 175, 265-275 (2006). (Pubitemid 44230827)
4. Baron, R. Mechanisms of disease: neuropathic pain-a clinical perspective. Nat. Clin. Pract. Neurol. 2, 95-106 (2006). (Pubitemid 43210250)
5. White, F. A., Jung, H. & Miller, R. J. Chemokines and the pathophysiology of neuropatic pain. Proc. Natl. Acad. Sci. USA 104, 20151-20158 (2012).
6. Watson, C. P. The treatment of neuropathic pain: antidepressant and opioids. N. Engl. J. Med. 343, 1563-5 (2000).
7. Hempenstall, K. et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2, 628-644 (2005).
8. Kennedy, J. D. Neuropatic pain molecular complexity underlines continuing unmet medical need J. Med. Chem. 50, 2547-2556 (2007). (Pubitemid 46896058)
9. Grothey, A. Clinical management of oxaliplatin-associated neurotoxicity. Clin. Colorectal. Cancer 1, S38-46 (2005).
10. Cersosimo, R. J.Oxaliplatin-associated neuropathy: a review. Ann. Pharmacother. 39, 128-35 (2004). (Pubitemid 40052388)
11. Andrade, E. L., Meotti, F. C. & Calixto, J. B. TRPA1 antagonists and potential drugs. Pharmacology & Therapeutics 133, 189-204 (2012).
12. Kiernan,M. C. The pain with platinum: oxaliplatin and neuropathy. Eur. J. Cancer 43, 2631-2633 (2007).
13. Argyriou, A. A., Bruna, J., Marmiroli, P. & Cavaletti, G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit. Rev. Oncol. Hematol. 82, 51-77 (2012).
14. Gauchan, P., Andoh, T., Kato, A. & Kuraishi, Y. Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice. Neurosci. Lett. 458, 93-95 (2009).
15. Nassini, R. et al. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain 152, 1621-1631 (2011).
16. Descoeur, J. et al. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol. Med. 3, 266-278 (2011).
17. Anderson, D.W. et al. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism. Eur. J. Neurosci. 28, 610-617 (2008). (Pubitemid 352040419)
18. Nativi, C., Ghelardini, C. & la Marca, G. Compounds with both analgesic and anti-hyperalgesic efficacy. PCT/IB2011/050018.
19. Saada, M. C. et al. Carbonic anhydrase activators: glod nanoparticles coated with derivatized histamine, histidine, and carnosine show enhanced activatory effects on several mammalian isoforms. J. Med. Chem. 54, 1170-1177 (2011).
20. Parcker, L., Witt, E. H. & Tritschler, H. J. Alpha-lipoic acid as a biological antioxidant. Free Radical Biol. Med. 19, 227-250 (1995).
21. Joseph, E. K., Chen, X., Bogen, O. & Levine, J. D. Oxaliplatin on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J. Pain 9, 463-472 (2008).
22. Hipkiss, A. R. Carnosine and its possible roles in nutrition and health. Adv. Food Nutr. Res. 57, 87-154 (2009).
23. Lipinski, C. A. et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting Adv. Drug Delivery Reviews 23, 3-25 (1997). (Pubitemid 27046991)
24. Scholz, J.& Woolf, C. J. The neuropatic pain triad: neurons, immune cells and glia. Nat. Neurosci. 10, 1361-1368 (2007). (Pubitemid 350014681)
25. Cavalletti, G. et al. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur. J. Cancer 37, 2457-2463 (2001).
26. Kannarkat, G., Lasher, E. E. & Schiff, D. Neurologic complications of chemotherapy agents. Current Opinion in Neurology 20, 719-725 (2007). (Pubitemid 350085017)
27. Wolf, S. et al. Chemotherapy induced peripheral neuropathy: prevention and treatment strategies. Eur. J. Cancer 44, 1507-1515 (2008).
28. Mitcheson, J. S. et al. A structural basis for drug-induced long QT syndrome. Proc. Natl. Acad. Sci USA 97, 12329-12333 (2000).
29. Roche, O. et al.AVirtual ScreeningMethod for Prediction of the hERG Potassium Channel Liability of Compound Libraries. ChemBioChem 3, 455-9 (2002). (Pubitemid 36002290)
30. Nilius, B., Appendino, G. & Owsianik, G. The transient receptor potential channel TRPA1: from gene to pathophysiology Pflugers Arch-Eur J Physiol 464, 425-458 (2012).
31. Karashima, Y. et al. TRPA1 acts as a cold sensor in vitro and in vivo. Proc. Natl. Acad. Sci USA 106, 1273-1278 (2009).
32. Karashima, Y. et al. Agonist-induced changes in Ca21 permeation through the nociceptor cation channel TRPA1. Biophysical J. 98, 773-783 (2010).
33. Zygmunt, P. M. A TRP(i)P in the air. Nature Chemical Biology 7, 661-663 (2011).
34. Gaggelli, E. & Valensin, G. 1H and 13C NMR Relaxation Investigation of the calcium complex of beta-alanyl-L-histidine (carnosine) in aqueous solution. J. Chem. Perkin Trans. 2, 401-406 (1990).